Prothena Corp. Plc (PRTA)
9.59
-0.02
(-0.21%)
USD |
NASDAQ |
Sep 02, 14:38
Prothena Net Income (TTM) : -43.99M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.99M |
| March 31, 2026 | -151.18M |
| December 31, 2025 | -244.09M |
| September 30, 2025 | -280.46M |
| June 30, 2025 | -302.92M |
| March 31, 2025 | -110.27M |
| December 31, 2024 | -122.31M |
| September 30, 2024 | -131.83M |
| June 30, 2024 | -50.92M |
| March 31, 2024 | -172.40M |
| December 31, 2023 | -147.03M |
| September 30, 2023 | -73.20M |
| June 30, 2023 | -140.87M |
| March 31, 2023 | -127.52M |
| December 31, 2022 | -116.95M |
| September 30, 2022 | -156.48M |
| June 30, 2022 | -1.466M |
| March 31, 2022 | 67.42M |
| December 31, 2021 | 66.98M |
| September 30, 2021 | 69.44M |
| June 30, 2021 | -70.39M |
| March 31, 2021 | -124.31M |
| December 31, 2020 | -111.14M |
| September 30, 2020 | -101.98M |
| June 30, 2020 | -90.85M |
| Date | Value |
|---|---|
| March 31, 2020 | -80.38M |
| December 31, 2019 | -77.68M |
| September 30, 2019 | -78.58M |
| June 30, 2019 | -83.70M |
| March 31, 2019 | -127.77M |
| December 31, 2018 | -155.64M |
| September 30, 2018 | -180.94M |
| June 30, 2018 | -208.78M |
| March 31, 2018 | -166.60M |
| December 31, 2017 | -153.24M |
| September 30, 2017 | -154.38M |
| June 30, 2017 | -145.23M |
| March 31, 2017 | -167.97M |
| December 31, 2016 | -160.11M |
| September 30, 2016 | -135.36M |
| June 30, 2016 | -115.10M |
| March 31, 2016 | -92.93M |
| December 31, 2015 | -80.61M |
| September 30, 2015 | -69.56M |
| June 30, 2015 | -59.77M |
| March 31, 2015 | -40.20M |
| December 31, 2014 | -7.15M |
| September 30, 2014 | -5.094M |
| June 30, 2014 | -1.601M |
| March 31, 2014 | -14.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alkermes Plc | 66.12M |
| Amarin Corp. Plc | -27.07M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 8.743B |
| Anika Therapeutics, Inc. | -3.121M |